Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 윤신교 | - |
dc.contributor.author | 김미소 | - |
dc.contributor.author | 홍용상 | - |
dc.contributor.author | 김한상 | - |
dc.contributor.author | 김승태 | - |
dc.contributor.author | 김지훈 | - |
dc.contributor.author | 윤홍석 | - |
dc.contributor.author | 유창훈 | - |
dc.contributor.author | 안희경 | - |
dc.contributor.author | 김효송 | - |
dc.contributor.author | 이인희 | - |
dc.contributor.author | 김인호 | - |
dc.contributor.author | 박인근 | - |
dc.contributor.author | 정재호 | - |
dc.contributor.author | 천재경 | - |
dc.contributor.author | 김진원 | - |
dc.contributor.author | 윤지나 | - |
dc.contributor.author | 임선민 | - |
dc.contributor.author | 차용준 | - |
dc.contributor.author | 장세진 | - |
dc.contributor.author | 장대영 | - |
dc.contributor.author | 김태원 | - |
dc.contributor.author | 강진형 | - |
dc.contributor.author | 김지현 | - |
dc.date.accessioned | 2022-05-11T01:40:07Z | - |
dc.date.available | 2022-05-11T01:40:07Z | - |
dc.date.created | 2022-01-11 | - |
dc.date.issued | 2022-01 | - |
dc.identifier.issn | 1598-2998 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/84260 | - |
dc.description.abstract | Next-generation sequencing (NGS) is becoming essential in the fields of precision oncology. With implementation of NGS in daily clinic, the needs for continued education, facilitated interpretation of NGS results and optimal treatment delivery based on NGS results have been addressed. Molecular tumor board (MTB) is multidisciplinary approach to keep pace with the growing knowledge of complex molecular alterations in patients with advanced solid cancer. Although guidelines for NGS use and MTB have been developed in western countries, there is limitation for reflection of Korea’s public health environment and daily clinical practice. These recommendations provide a critical guidance from NGS panel testing to final treatment decision based on MTB discussion. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한암학회 | - |
dc.relation.isPartOf | Cancer Research and Treatment | - |
dc.title | Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000788852400001 | - |
dc.identifier.doi | 10.4143/crt.2021.1115 | - |
dc.identifier.bibliographicCitation | Cancer Research and Treatment, v.54, no.1, pp.1 - 9 | - |
dc.identifier.kciid | ART002802574 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85123602472 | - |
dc.citation.endPage | 9 | - |
dc.citation.startPage | 1 | - |
dc.citation.title | Cancer Research and Treatment | - |
dc.citation.volume | 54 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | 안희경 | - |
dc.contributor.affiliatedAuthor | 박인근 | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Next-generation sequencing | - |
dc.subject.keywordAuthor | Molecular tumor board | - |
dc.subject.keywordAuthor | Advanced solid cancer | - |
dc.subject.keywordAuthor | Precision medicine | - |
dc.subject.keywordAuthor | Genomic alterations | - |
dc.subject.keywordPlus | DEAMINATION | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | PANELS | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.